MetaSystems Probes has received IVDR certification for our initial 26 fluorescence in situ hybridization (FISH) probes from the notified body, BSI. Achieving this milestone was not without its challenges, and we are delighted to have accomplished IVDR certification for this probe set at an early stage.
XL ROS1-GOPC BA
Break Apart Probe
- Order Number
- D-6029-100-OG
- Package Size
- 100 µl (10 Tests)
- Chromosome
- 066
- Regulatory Status
- IVDD
IVDR Certification
MetaSystems Probes has already certified a large part of its portfolio, according to IVDR. For organizational reasons, we currently provide only the IVDD product.
Discover all IVDR-certified productsXL ROS1-GOPC BA consists of a green-labeled probe hybridizing proximal to the ROS1 gene region at 6q22.1 and an orange-labeled probe hybridizing distal to the ROS1 gene region at 6q22.1.
Probe maps are created in accordance with the intended purpose of the product. Solid colored bars do not necessarily indicate that the probe fully covers the indicated genomic region. Therefore, caution is advised when interpreting results generated through off-label use. Probe map details based on UCSC Genome Browser GRCh37/hg19. Map components not to scale. Further information is available on request.
Translocations involving the ROS1 receptor tyrosine kinase gene have recently been described in a subset of non-small-cell lung cancers (NSCLCs). Chromosomal rearrangements involving the ROS1 gene were originally described in glioblastomas, where ROS1 is fused to the GOPC gene by an interstitial deletion.
Fusions of ROS1 with other genes lead to constitutive kinase activity and are associated with in vitro sensitivity to tyrosine kinase inhibitors such as crizotinib.
Clinical Applications
- Solid Tumors (Solid Tumors)
Normal Cell:
Two green-orange (2GO) fusion signals.
Aberrant Cell (typical results):
One green (1G), one orange (1O), and one green-orange (1GO) fusion signal.
Aberrant Cell (typical results):
One green (1G) and one green-orange (1GO) fusion signal.
- Charest et al (2003) Genes Chrom Cancer 37:58-71
- Takeuchi et al (2011) Nat Med 18:378-381
- Bergethon et al (2012) J Clin Oncol 30:863-870
Certificate of Analysis (CoA)
or go to CoA Database